Travere Therapeutics

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Travere chief makes way for former Amicus CEO—Chutes & Ladders

Travere chief makes way for former Amicus CEO. Ex-Cue CEO takes the reins at Lift. Nuclera’s new leader sets sights on growth.
View of Mt Everest from Base Camp

Travere scales Everest with $1.1B deal for BTK inhibitor

Jun 2, 2026 10:30am
Lifeline

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm
MA strategy deal block push come together form

Amicus pays Dimerix $30M for late-phase rare kidney disease drug

May 1, 2025 10:59am
stock market down crash fail shares

Travere fails to beat off-label blood pressure drug in phase 3

May 2, 2023 7:00am
FDA

FDA’s liver safety request set to delay decision on Travere drug

Oct 14, 2022 10:05am